Open AccessA Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease
Author(s) -
David M. Marks,
ChiUn Pae,
Ashwin A. Patkar
Publication year - 2014
Publication title -
the primary care companion for cns disorders
Language(s) - English
Resource type - Journals
eISSN - 2155-7772
pISSN - 2155-7780
DOI - 10.4088/pcc.14m01658
Subject(s) - milnacipran , sciatica , lumbosacral joint , medicine , radicular pain , placebo , double blind , anesthesia , placebo controlled study , chronic pain , lumbar , surgery , physical therapy , antidepressant , alternative medicine , pathology , hippocampus
The current study investigates whether milnacipran, an equipotent serotonin-norepinephrine reuptake inhibitor, is effective in reducing chronic radicular pain in patients (N = 11) with lumbosacral disc disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom